Legal Representation
Attorney
OLIVER R. CHERNIN
USPTO Deadlines
Application History
23 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Sep 7, 2004 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Aug 3, 2004 | CFIT | O | CASE FILE IN TICRS | Loading... |
| Jun 3, 2004 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Apr 5, 2004 | I | PAPER RECEIVED | Loading... | |
| Dec 5, 2003 | I | PAPER RECEIVED | Loading... | |
| Dec 3, 2003 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Dec 3, 2003 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Jun 4, 2003 | I | PAPER RECEIVED | Loading... | |
| Jun 2, 2003 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Jun 2, 2003 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| May 19, 2003 | I | PAPER RECEIVED | Loading... | |
| May 15, 2003 | I | PAPER RECEIVED | Loading... | |
| Dec 3, 2002 | NOAM | O | NOA MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Sep 10, 2002 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Aug 21, 2002 | NPUB | O | NOTICE OF PUBLICATION | Loading... |
| Apr 26, 2002 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Apr 8, 2002 | CNEA | O | EXAMINERS AMENDMENT MAILED | Loading... |
| Nov 19, 2001 | CNFR | O | FINAL REFUSAL MAILED | Loading... |
| Oct 9, 2001 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Aug 20, 2001 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Apr 4, 2001 | UNPR | I | UNRESPONSIVE/DUPLICATE PAPER RECEIVED | Loading... |
| Feb 23, 2001 | CNRT | F | NON-FINAL ACTION MAILED | Loading... |
| Feb 8, 2001 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Detailed Classifications
Class 040
Custom manufacture of chemicals featuring combinatorial and medicinal chemistry technologies for the purpose of creating drug leads
First Use Anywhere:
0
First Use in Commerce:
0
Class 042
Pharmaceutical research and testing services featuring combinatorial and medicinal chemistry for the purpose of creating drug leads
First Use Anywhere:
0
First Use in Commerce:
0
Additional Information
Other
THE STIPPLING IS FOR SHADING PURPOSES ONLY AND DOES NOT INDICATE COLOR.
Classification
International Classes
040
042
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"TECHNOLOGIES" or "INTERNATIONAL COMPANY"